GST notices to pharma firms on free supply to have wider ramifications

Notices sent by the tax department to major pharma companies over not cutting the  Goods and Services Tax  (GST) on free supplies to retailers are likely to have repercussions on fast-moving consumer goods (FMCG) companies as well, warn tax experts, who found no ground for the notices. The notices sent by the Directorate General of  Goods and Services Tax  Intelligence (DGGI) s…